2017
DOI: 10.5811/westjem.2016.12.33224
|View full text |Cite
|
Sign up to set email alerts
|

Management of Sickle Cell Disease Super Utilizers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 8 publications
1
1
0
Order By: Relevance
“…However, most studies on ED use tend to report on overall utilization in the SCD population with a focus on superutilizers and ED visit reduction approaches. 4,5,7,11,19,[28][29][30][31][32][33][34][35] Similar to some of these studies, our study also found that the majority of participants were not high ED utilizers. 11 However, the stigma and pervasive negative ED experiences have been empirically noted across our study and several others.…”
Section: Discussionsupporting
confidence: 89%
“…However, most studies on ED use tend to report on overall utilization in the SCD population with a focus on superutilizers and ED visit reduction approaches. 4,5,7,11,19,[28][29][30][31][32][33][34][35] Similar to some of these studies, our study also found that the majority of participants were not high ED utilizers. 11 However, the stigma and pervasive negative ED experiences have been empirically noted across our study and several others.…”
Section: Discussionsupporting
confidence: 89%
“…23 Th ese individuals have a signifi cantly shorter lifespan and higher morbidity (e.g., acute life-threatening diseases such as acute chest syndrome and stroke) compared with other adults. 24,25 Most families aff ected by SCD have no systematic way to engage in or lend their expertise to health research that could bring barriers to care to the forefront. Th is suggests an urgent need to engage individuals with SCD to address this void in health-related research.…”
mentioning
confidence: 99%